Skip to main content

Translational Research in Oncology-US FKA Translational Onc Res Intl Inc

Los Angeles, California·EIN 20-0132719·NTEE H30 · Medical Research·501(c)(3)·Filing year 2024

Translational Research in Oncology-US FKA Translational Onc Res Intl Inc's highest-paid officer, the COO, was reported at $402,739 for 2024 (IRS Form 990), including base pay and other compensation. Reported COO pay ranged from $393,743 to $402,739 between 2023 and 2024.

Total revenue
$9.7M
Total assets
$25.8M
Total expenses
$9.6M
Reported officers
4

How Translational Research in Oncology-US FKA Translational Onc Res Intl Inc’s pay compares

Compared with private foundations of similar size nationwide.

There were too few similar organizations to compare with, so this group goes beyond California and covers all sectors.

Varies by role

Translational Research in Oncology-US FKA Translational Onc Res Intl Inc’s roles do not land on one side. Some are paid below these private foundations and some are paid at or above them.

Show how each role compares

From the officer pay Translational Research in Oncology-US FKA Translational Onc Res Intl Inc reported on its latest IRS Form 990.

Executive compensation

Form 990-PF · Part VIII · 2 reported individuals · Filing year 2024

Percentile bands compare each position's total pay with the same role at private foundations of similar size nationwide. There were too few similar organizations to compare with, so this group goes beyond California and covers all sectors.

COO
Above 90th percentile
$403k
CFO
Median to 75th percentile
$231k

Plus 2 unpaid individuals.

Browse compensation in Medical Research →

Top pay as a share of expenses

In 2024, the highest total compensation at Translational Research in Oncology-US FKA Translational Onc Res Intl Inc equaled 4% of the organization's total expenses. The median for medical research organizations is 10%.

This organization (2024)
4%
Sector median
10%
Middle half of sector
4% to 21%

Based on 1,118 medical research organizations, each measured at its most recent filing year with reported expenses and compensation.

Up 2%
from 2023

From $394k in 2023 to $403k in 2024.

$394k
2023
$403k
2024
Pay for the position

Chief Operating Officer pay rose 2% from 2023 to 2024, while revenue rose 14%.

$394k in 2023 to $403k in 2024.
  • Chief Financial Officer pay rose 2% from 2023 to 2024.

Pay for the position itself, not any one person. The officeholder may have changed between 2023 and 2024.

Highest reported compensation in each year. Volunteer board members and partial-year payouts are filtered out.

This is a private foundation. Peers are foundations of similar asset size ($25M–$50M), because foundation pay scales with assets under management, not revenue.

Among peers

Revenue and top compensation, plotted against similar organizations. This organization is highlighted in cyan.

1
Hopelab Foundation Inc2024
$643k
2
Translational Research in Oncology-US FKA Translational Onc Res Intl Inc2024
$403k
See full COO compensation rankings across Medical Research

Common questions about Translational Research in Oncology-US FKA Translational Onc Res Intl Inc

What does the Chief Operating Officer of Translational Research in Oncology-US FKA Translational Onc Res Intl Inc earn?

In 2024, the Chief Operating Officer of Translational Research in Oncology-US FKA Translational Onc Res Intl Inc received $402,739 in total compensation. This pay is in the top 10% for Chief Operating Officer roles among private foundations of similar size nationwide: at least 9 in 10 comparable filings report less. Based on IRS Form 990 data.

How does Chief Operating Officer pay at Translational Research in Oncology-US FKA Translational Onc Res Intl Inc compare with similar nonprofits?

Compared with the same role at private foundations of similar size nationwide, the 2024 pay of the Chief Operating Officer at Translational Research in Oncology-US FKA Translational Onc Res Intl Inc falls in the top 10%. In 2024, the highest total compensation at Translational Research in Oncology-US FKA Translational Onc Res Intl Inc equaled 4% of the organization's total expenses. The median for medical research organizations is 10%.

What are Translational Research in Oncology-US FKA Translational Onc Res Intl Inc's revenue and expenses?

In 2024, Translational Research in Oncology-US FKA Translational Onc Res Intl Inc reported $9.7M in total revenue and $9.6M in total expenses on its IRS Form 990.